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Abstract
Background: The accuracy of step detection in consumer-based wearable activity monitors in older adults with varied ambulatory abilities is 
not known.
Methods: We assessed the validity of two hip-worn (Fitbit One and Omron HJ-112) and two wrist-worn (Fitbit Flex and Jawbone UP) 
activity monitors in 99 older adults of varying ambulatory abilities and also included the validity results from the ankle-worn StepWatch as a 
comparison device. Nonimpaired, impaired (Short Physical Performance Battery Score < 9), cane-using, or walker-using older adults (62 and 
older) ambulated at a self-selected pace for 100 m wearing all activity monitors simultaneously. The criterion measure was directly observed 
steps. Intraclass correlation coefficients (ICC), mean percent error and mean absolute percent error, equivalency, and Bland–Altman plots were 
used to assess accuracy.
Results: Nonimpaired adults steps were underestimated by 4.4% for StepWatch (ICC = 0.87), 2.6% for Fitbit One (ICC = 0.80), 4.5% 
for Omron HJ-112 (ICC = 0.72), 26.9% for Fitbit Flex (ICC = 0.15), and 2.9% for Jawbone UP (ICC = 0.55). Impaired adults steps were 
underestimated by 3.5% for StepWatch (ICC = 0.91), 1.7% for Fitbit One (ICC = 0.96), 3.2% for Omron HJ-112 (ICC = 0.89), 16.3% for 
Fitbit Flex (ICC = 0.25), and 8.4% for Jawbone UP (ICC = 0.50). Cane-user and walker-user steps were underestimated by StepWatch by 1.8% 
(ICC = 0.98) and 1.3% (ICC = 0.99), respectively, where all other monitors underestimated steps by >11.5% (ICCs < 0.05).
Conclusions: StepWatch, Omron HJ-112, Fitbit One, and Jawbone UP appeared accurate at measuring steps in older adults with nonimpaired 
and impaired ambulation during a self-paced walking test. StepWatch also appeared accurate at measuring steps in cane-users.
Keywords: Physical activity—Exercise—Pedometer—Accelerometer—Accuracy
Regular engagement in physical activity promotes health and reduces 
risk factors for many chronic diseases in older adults (1,2). However, 
two-thirds of older adults in the United States do not meet the physi-
cal activity guidelines of 150 minutes of moderate intensity physical 
activity a week and an additional 20% do not engage in any daily 
leisure-time physical activity (3). Two-thirds of older adults also cite 
walking as their most preferred method of physical activity (4,5); 
therefore, tools and strategies to increase walking are a critical target 
for this population. Wearable activity monitors may be an effective 
tool in aiding older adults to manage their walking activities and to 
encourage them to walk more.
The consumer wearable activity monitor market is growing at an 
incredible rate with an expected 20 million units being sold in 2015.
(6) Many of the activity monitors responsible for this growth have 
been validated in the general population (ie, children, healthy adults, 
obese individuals) (7–10). Use of activity monitors by older adults is 
also increasing (11); however, there are very few validation studies 
for this population. One study assessed the accuracy of a smartphone 
device to track steps in middle- and older-aged adults and found 
strong correlations with a research-grade accelerometer (ActiGraph, 
Fort Walton, FL) (12). Even less is known about activity monitors 
in measuring step activity in older adults with altered ambulation 
abilities. Older adults often have a slower or altered gait compared to 
younger individuals and may use assistive devices (eg, cane, walker) 
that are likely to have an impact on monitor accuracy. For this popu-
lation, monitor location (eg, wrist, hip, ankle) and the sensitivity of 
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monitor algorithm technology to detect true stepping must be con-
sidered. The limited testing of activity monitors in older adults is only 
beginning to identify some of the difficulties encountered when assess-
ing step activity in individuals who may have altered walking patterns. 
For example, Laurtizen and coworkers (13) reported low accuracy 
and precision in two consumer-based monitors when measuring steps 
in older adults with an altered gait pattern or very slow gait.
The purpose of this study was to test the accuracy of four con-
sumer-based activity monitors worn at different locations on the 
body to measure steps during ambulatory activity. We added the 
StepWatch activity monitor to the study to serve as a field-based 
reference to aid in interpretation of the other devices. Additionally, 
as a consumer-based ankle-mounted model was not available at the 
time of the study, these results may show how valid and reliable a 
future consumer model could be on the ankle. The activity monitors 
were selected based on varied locations: StepWatch (ankle), Fitbit 
One (hip), Omron HJ-112 (hip), Fitbit Flex (wrist), and Jawbone UP 
(wrist). Accuracy was assessed in four groups of older adults with 
varying levels of ambulatory ability: nonimpaired walkers, impaired 
walkers, cane-users, and walker-users.
Methods
Participants
Older adults from two suburban community centers and a senior 
mixed-living community in a large metropolitan area (through 
researcher presentations or flyers) were invited to participate in 
the study. Participants were eligible if they (a) were 62  years or 
older; (b) met the health conditions on a modified Physical Activity 
Readiness Questionnaire-Revised (14) such as stable blood pressure 
for 3 months, no reports of chest pain with activity or joint problems 
limiting physical activity; (c) able to walk 100 m without stopping 
with or without an assistive device; (d) able to speak and under-
stand English; and (e) willing to wear all activity monitors during the 
study. Approval was obtained prior to the study from the University 
Institutional Review Board.
Participants were informed of study procedures and provided 
consent prior to participation. If participants stated they were cur-
rently using a cane or walker as an assistive device for most walk-
ing activities, they were classified into that specific testing group. If 
they did not indicate an ambulatory assistive device, we adminis-
tered the Short Physical Performance Battery test to classify them 
as a “nonimpaired walker” (Short Physical Performance Battery 
≥ 9) or “impaired walker” (Short Physical Performance Battery < 9). 
The Short Physical Performance Battery scores highest in reliability, 
validity, and responsiveness, and has been extensively investigated 
in different populations of older adults ranging from highly active 
to frail (15).
Instruments
We tested the accuracy of measured steps of four widely available 
consumer-based activity monitors. The Fitbit One and Omron HJ-112 
were mounted on the nondominant hip. The Fitbit Flex and Jawbone 
UP were mounted on the nondominant wrist. We also included accu-
racy of measured steps for the StepWatch activity monitor mounted 
to the nondominant ankle to serve as a previously validated monitor 
reference. Specifications for each monitor are found in Table 1.
Procedures
Data were collected between October 2013 and April 2014. 
Participants were instructed to walk at a self-selected pace along an 
unobstructed 100-m predetermined, flat marked route at their respec-
tive community center location. The 100-m distance was selected to 
accommodate all ambulation categories of the study population as 
many older adults with impaired ambulation or who use assistive 
devices may not have the ability to ambulate continuously for longer 
distances (16). Participants were encouraged to walk at their normal 
walking pace and use their assistive device as was comfortable.
Measures
Demographic and physical characteristics reported by the partici-
pant included age, gender, height and weight, level of ambulatory 
ability, and dominant hand use. Participants were fitted with the five 
activity monitors on the nondominant side of the body according 
to manufacturer guidelines in a fixed placement order. The criterion 
measurement of steps was obtained by direct observation through 
continuous videography. Steps were counted by two independent 
observers with very high interrater reliability (intraclass correlation 
[ICC] = 0.99). Steps recorded by the StepWatch were downloaded to 
Table 1. Description of Activity Monitors
Instrument Manufacturer Placement Measures and Programming
StepWatch OrthoCare Innovations, Mountlake Terrace, WA Ankle Dual-axial accelerometer that measures step counts and 
step rates per unit time; programmed and downloaded via 
software interface (Mac/PC); records for up to 2 months
Fitbit One Fitbit, San Francisco, CA Hip Triaxial accelerometry monitor assesses physical activity 
patterns; syncs wired (via USB) to computer or wireless 
(Bluetooth) to iOS, Android monitor; 7-day charge from 
USB charging cable
Omron (HJ-112) Omron Healthcare, Bannockburn, IL Hip Dual-axial accelerometer that measures steps and estimated 
activity level based on stride; on-screen display; battery- 
powered with 7-day memory
Fitbit Flex Fitbit, San Francisco, CA Wrist Triaxial accelerometry monitor assesses physical activity 
patterns; syncs wirelessly to tablets, computers, iOS, 
Android, and Windows smartphones using Bluetooth 4.0 
wireless technology; 5-day charge from USB charging cable
Jawbone UP JAWBONE, San Francisco, CA Wrist Triaxial accelerometry monitor assesses sleep and physical 
activity patterns; syncs data with iPhone or Android using 
attached cable connection; 10-day charge
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a computer and marked based upon recorded start and stop times 
for the activity. Steps recorded by the Fitbit One, Omron (HJ-112), 
Fitbit Flex, and Jawbone UP were captured directly from the moni-
tor display or synced smartphone immediately prior and following 
the walking activity while the participant was motionless.
Statistical Analysis
Data were cleaned, and Bland–Altman plots were produced using 
SAS 9.4. All other statistical analyses were performed using SPSS 
version 21. Descriptive statistics were computed for each walking 
category. Accuracy relative to the criterion of direct observation 
was assessed first with the ICC. Specifically, we used ICCs (2,1) 
with absolute agreement, which are used to assess the agreements 
between two or more measurements. The ICCs (2,1) account for 
both agreement of performances between the two measures in the 
same individual (within-subject differences) and change in average 
performance of participants as a group between the two measures (ie, 
between-subject differences). ICC values >0.75 were interpreted as 
excellent, 0.40–0.75 were fair to good, and <0.40 were poor (17). We 
also assessed accuracy by calculating mean percent error ([activity 
Table 2. ICC (95% CI), Mean Percent Error (95% CI), and Absolute Percent Error (95% CI) by Ambulatory Category
ICC MPE MAPE
Nonimpaired (N = 25)
 StepWatch 0.87 (0.68, 0.95) −4.42 (−0.41, −8.43) 5.25 (1.45, 9.05)
 Fitbit One 0.80 (0.60, 0.91) −2.59 (0.04, −5.23) 2.69 (0.07, 5.31)
 Omron 0.72 (0.42, 0.87) −4.48 (−1.20, −7.76) 4.47 (1.19, 7.76)
 Fitbit Flex 0.15 (−0.12, 0.45) −26.94 (−14.26, −39.61) 27.65 (15.27, 40.03)
 Jawbone UP 0.55 (0.21, 0.78) −2.86 (4.32, −10.04) 10.87 (5.20, 16.53)
Impaired (N = 25)
 StepWatch 0.91 (0.74, 0.97) −3.45 (0.06, −6.96) 3.76 (0.34, 7.18)
 Fitbit One 0.96 (0.88, 0.99) −1.71 (−0.69, −2.73) 1.81 (0.82, 2.79)
 Omron 0.89 (0.63, 0.96) −3.15 (−1.37, −4.93) 3.21 (1.45, 4.96)
 Fitbit Flex 0.25 (−0.10, 0.69) −16.31 (−10.90, −21.71) 16.30 (10.90, 21,70)
 Jawbone UP 0.50 (0.10, 0.75) −8.43 (−2.93, −13.92) 9.50 (4.34, 14.66)
Cane-user (N = 25)
 StepWatch 0.98 (0.95, 0.99) −1.78 (0.06, −3.61) 2.29 (0.57, 4.01)
 Fitbit One −0.16 (−0.19, 0.50) −11.48 (−1.84, −21.11) 11.47 (1.84, 21.11)
 Omron −0.61 (−0.37, 0.32) −17.64 (−3.23, −32.06) 18.56 (4.37, 32.75)
 Fitbit Flex 0.05 (−0.27, 0.41) −22.88 (−4.57, −41.19) 35.89 (21.77, 50.01)
 Jawbone UP −0.04 (−0.31, 0.29) −34.10 (−13.44, −54.75) 46.03 (29.77, 62.29)
Walker-user (N = 24)
 StepWatch 0.99 (0.98, 0.99) −1.33 (0.57, −3.22) 1.75 (−0.05, 3.56)
 Fitbit One −0.38 (−0.58, 0.13) −23.25 (−8.99, −37.51) 23.25 (8.99, 37.51)
 Omron −0.16 (−0.37, 0.19) −33.72 (−17.84, −49.61) 33.72 (17.83, 49.61)
 Fitbit Flex −0.03 (−0.13, 0.16) −57.40 (−44.36, −70.43) 57.39 (44.35, 70.43)
 Jawbone UP −0.01 (−0.05, 0.07) −94.27 (−83.71, −104.84) 95.36 (87.04, 103.67)
Notes: CI = confidence interval; ICC = intraclass correlation coefficients; MAPE = mean absolute percent error; MPE = mean percent error.
Figure 1. Equivalency plots by ambulatory category.
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monitor recorded steps − direct observation/direct observation] × 
100). Mean percent error allows us to obtain the direction of the 
error of measurement by each device. Positive values indicate overes-
timates of steps and negative values indicate underestimates relative 
to the criterion. Additionally, we calculated mean absolute percent 
error ([|activity monitor recorded steps − direct observation|/direct 
observation] × 100)  to obtain the magnitude of the error. Larger 
mean absolute percent error values indicate more error in step esti-
mates whereas smaller values indicate less error relative to the crite-
rion. Equivalency testing was used to examine whether each one of 
the activity monitors under assessment was statistically equivalent to 
the criterion. Equivalency testing is an alternative approach to test-
ing for significant difference (in which the evidence of a difference 
does not necessarily indicate equivalency) (18). When conducting 
equivalency testing it is necessary to identify a clinically meaning-
ful equivalence range also known as equivalence zone. Comparisons 
between the activity monitors and the equivalence zone can then be 
performed, and, if the full 90% confidence interval of a monitor lies 
within the equivalence zone, it can be concluded with 95% confi-
dence that the test sensor is equivalent to the criterion. An equiva-
lence zone of ±10%, while arbitrary, is consistent with other activity 
monitor validation studies (8,19). To assess systematic variation 
between activity monitor and observation, Bland–Altman plots (20) 
were derived for each monitor against the criterion. In addition to the 
traditional display on the Bland–Altman plot, we included a regres-
sion in which the difference score between methods was regressed 
upon the average of the two scores. This regression line provides 
information on whether the activity monitor value becomes more or 
less accurate at varying levels of the criterion; thus, a slope close to 
zero (flat regression) line indicates that the step estimate of the activ-
ity monitor varies in the same manner as the criterion value. If the 
slope is not close to zero, the activity monitor is positively or nega-
tively biased when compared to the criterion. In all statistical tests, p 
< .05 was considered significant.
Results
A total of 99 older adults completed the study protocol. Participants 
were 71% female, 78.9 ± 8.6  years of age (range: 62–101  years), 
and body mass index  =  28.0 ± 6.5 kg/m2. Nonimpaired (N  =  25, 
72% female) participants were 74.3 ± 6.3 years. Impaired ambula-
tors’ (N = 25, 72% female) age was 79.2 ± 7.4 years, and cane-users’ 
Figure 2. Bland–Altman plots for nonimpaired ambulators (N = 25).
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(N = 25, 64% female) age was 77.6 ± 9.8 years. Walker-users (N = 24, 
75% female) were significantly older than their nonimpaired peers 
with an age of 84.8 ± 8.7 years (p < .001). Gender distribution and 
body mass index were similar across ambulatory ability levels.
Table  2 displays ICCs, mean percent error, and mean absolute 
percent error with 95% confidence intervals for the five activity mon-
itors by ambulatory ability levels. StepWatch had high accuracy in all 
walking categories (ICCs for all walking categories >0.87). Fitbit One, 
Omron, and Jawbone UP were more accurate when measuring non-
impaired and impaired walking groups; however, accuracy was poor 
for these three monitors when measuring steps in cane- and walker-
user groups. Fitbit Flex had very poor ICC values in all groups. All of 
the tested activity monitors underestimated steps to a different extent 
across the four walking categories. Overall, StepWatch had the low-
est underestimation across all walking categories. Fitbit One, Omron, 
and Jawbone UP had <10% underestimation in the nonimpaired and 
impaired ambulatory categories; however, underestimation increased 
substantially in the cane- and walker-user groups. Fitbit Flex underes-
timated steps by markedly high levels. Mean percent error and mean 
absolute percent error results were similar across devices, suggesting 
the direction of error (underestimation) was consistent within each 
device and across all devices.
Figure 1 displays results from equivalency testing. None of the 
activity monitors were within the equivalence zone across all walk-
ing groups. Fitbit One was the only device that was equivalent to 
the criterion for the nonimpaired walking groups with marginal 
equivalence for StepWatch, Omron, and Jawbone UP. Three activ-
ity monitors (StepWatch, Fitbit One, and Omron) were equivalent 
to the criterion for the impaired walking group. StepWatch was the 
only activity monitor equivalent to the criterion for the cane-user 
group. None of the activity monitors were equivalent to the criterion 
for walker-user group, although StepWatch bordered equivalence.
Bland–Altman plots are shown in Figures 2–5 for nonimpaired, 
impaired, cane-users, and walker-users, respectively. Limits of agree-
ment for StepWatch were narrow across all walking groups without 
important variation. Wide limits of agreement with larger scat-
ter were observed in the cane-user (see Figure 4) and walker-user 
(see Figure 5) groups for Fitbit One, Omron, Fitbit Flex, and Jawbone 
UP. Significant variation was observed in Omron, Fitbit Flex, and 
Jawbone UP for the cane-user group (see Figure 4).
Figure 3. Bland–Altman plots for impaired ambulators (N = 25).
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Discussion
Activity monitors are increasingly popular among older adults (11). 
Monitors that provide accurate information are needed for this 
population. Our study is one of the first to compare various con-
sumer-based monitors in the older adult population across varying 
ambulatory abilities. These results show that monitor location may 
be an important consideration for older adults with various gait pat-
terns and/or who use assistive devices. The best results were observed 
for the ankle-mounted device, with acceptable values also present 
at the hip, and in some walking groups acceptable on the wrist (eg, 
Jawbone UP with nonimpaired and impaired walkers). However, 
algorithm differences clearly also contribute to accuracy even when 
considering different devices at the same location. This was evident in 
our study based upon the measurement differences observed between 
the two wrist-worn monitors, Fitbit Flex and Jawbone UP.
For older adults with nonimpaired and impaired ambulation, 
placement of activity monitors at all three locations—wrist, waist, 
or ankle—seemed to yield relatively accurate results at normal 
walking speeds. Older adults may prefer use of monitors easily man-
aged on the wrist or waist. Older adults using a cane may require an 
ankle-mounted monitor or a waist worn monitor sensitive enough 
to capture slight changes in gait or balance. An ankle-mounted activ-
ity monitor may be the only option for accurate step counting in 
older adults who use a walker to assist with ambulation. Further 
investigation is needed with consumer-based ankle monitors to test 
for accuracy, as the StepWatch is not typically used outside of clini-
cal contexts. It has a significantly higher cost and requires more 
extensive software/computer equipment than most consumer moni-
tors on the market. At the time of the study, however, other ankle-
worn monitors were not feasible. It may be more useful to apply a 
monitor to roller-walkers that measures distance to estimate steps in 
that population. Before validation in free-living conditions, studies 
should address the acceptability of use of these monitors by the older 
adult population as they may have different learning needs regarding 
digital monitor interaction (21,22). Devices should be easily man-
ageable for a population that may have reduced vision and muscle 
dexterity, for example.
Figure 4. Bland–Altman plots for cane-users (N = 25). 
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Consumer-based activity monitors may be a valuable tool to 
support older adults to track and manage their physical activity 
levels, along with other health outcomes such as sleep and dietary 
intake. Additionally, they may provide valuable health data for 
older adults to share with their clinicians. The ability to accurately 
assess activity patterns across days and weeks—with ease of use 
and at a relatively low cost—may support physical activity promo-
tion strategies that are tailored to the needs of older adults. These 
monitors may be easily adopted in clinical settings as an added 
assessment tool.
Strengths
There are several strengths of this study. First, the very high interrater 
reliability (ICC = 0.99) for the criterion measure assures very little 
measurement error. Second, to our knowledge, this is the first study 
to test the accuracy of several monitors in different body locations 
across a wide range of older adults with varied ambulatory abili-
ties. The use of multiple monitors in three separate locations high-
lights the potential variations in algorithm technology that should 
be addressed for use in the older adult population. These findings 
are in line with earlier results from Tudor-Locke and coworkers (23) 
who identified the need for appropriate algorithm development for 
individual monitors in specific ambulatory groups.
Limitations
There are a few limitations of this study. First, we tested activity 
monitor measurement in only one prescribed walking activity. This 
limits generalizability to other free-living conditions in this popu-
lation. We chose this single activity considering the safety for this 
population. Second, it is possible that monitor placement—on the 
dominant or nondominant side—may cause an error in estimation of 
steps due to changes in arm swing or gait related to their disability. 
It is also unknown if there is a hand dominance effect for cane-users. 
We could not test the difference in this study as our cane-user sample 
population was relatively small, and among those only four partici-
pants used their cane with the nondominant hand. However, we did 
not observe any differences in accuracy among these four individu-
als. Lastly, the StepWatch is not a typical consumer-based activity 
monitor; therefore, results may not translate to other ankle-worn 
consumer monitors on the market.
Figure 5. Bland–Altman plots for walker-users (N = 24).
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Conclusion
The use of consumer-based, objective activity monitors may be a 
realistic option to assist older adults to manage or improve their 
physical activity levels. However, this study shows that one device 
does not “fit all.” Consideration of the individual’s ambulatory pat-
tern and/or limitation is needed to ensure accurate step detection. 
Placement of a device at the wrist, hip, or ankle should be investi-
gated based on the older adult’s walking pattern and use of assistive 
equipment. Additionally, monitor sensitivity to detect true steps in 
older adults with varied gait patterns such as shuffling should be 
considered when selecting a device.
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